Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Claudia Senesac, PT, PhD, PCS
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Duchenne Muscular Dystrophy (DMD) is the most common childhood muscular dystrophy. Much of what we have known about this disease has been based on years of clinical observation, muscle biopsy, and other limited testing. Longitudinal studies and clinical trials are shaping our "new understanding" of this disease. The courses related to DMD will span pathophysiology, research, the development of therapy recommendations, and quality of life issues. Therapy recommendations are based on predictive models of biomarkers and function, helping therapists and families plan for the future. Therapists play a critical role in caring for boys and young men with this disease.
Claudia Senesac, PT, PhD, PCS
Claudia Senesac is a clinical associate professor at University of Florida in the Doctor of Physical Therapy department. Her teaching responsibilities include functional anatomy dissection and pediatrics in physical therapy. She has over 37 years of pediatric clinical experience. She has been the owner and administrator of a pediatric physical therapy private practice since 1984…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. What We Know Now
The chapter will provide foundational background information to enhance the participants' understanding of DMD. Signs and symptoms of this disease will be detailed and the process of differential diagnosis reviewed. The most common medications and supplements will be covered.
2. Identified Biomarkers
Identified biomarkers have helped to further our understanding of this disease and monitor disease progression. Selected biomarkers have been developed and are emerging as outcome measures in research.
3. Research and Understanding DMD
Longitudinal research studies shed light on our current understanding of DMD. Correlations of multiple outcomes help make predictions for function. Predictions of function allow for planning for the future.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Contact sales to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.